ERBB2 and breast cancer: To further analyze whether this approach can also be used for endogenous cell surface epitopes, we selected a Nb (2Rs15d), which has been previously described to bind human epidermal growth factor receptor 2 (HER2) - a plasma membrane receptor widely expressed in breast cancer (Vaneycken et al., 2011).